Fludrocortisone Acetate from Japan
Fludrocortisone acetate is a synthetic 9α-fluorinated mineralocorticoid derived from adrenal cortical hormones, used primarily for hormone replacement in Addison's disease. Classified in HTS 2937.22.00.00 as it features halogen substitution and qualifies as a steroidal hormone under Chapter 29 definitions.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Declare acetate ester content precisely (typically 97-102% as is); hydrolysis products misclassify as parent alcohol
• Include bioequivalence data if generic API; FDA requires comparative dissolution profiles